The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - ACT Genomics; AstraZeneca; Eisai; Lilly; Novartis; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Eisai; Lilly; Novartis; Pfizer; Roche
Research Funding - Eisai; Pfizer; Taiho Pharmaceutical
Travel, Accommodations, Expenses - Amgen; Pfizer
A phase Ib/II trial of lenvatinib (len) and letrozole (let) incorporating pharmacodynamics studies in postmenopausal women with hormone receptor positive (HR+) locally advanced/metastatic breast cancer (LABC/MBC).
 
Joline Si Jing Lim
Consulting or Advisory Role - Pfizer; Pfizer
Travel, Accommodations, Expenses - AstraZeneca; Novartis
 
Andrea Li Ann Wong
Honoraria - Novartis; Pfizer
Research Funding - Otsuka
Travel, Accommodations, Expenses - Eisai; Pfizer
 
Samuel Guan Wei Ow
No Relationships to Disclose
 
Lim Siew Eng
No Relationships to Disclose
 
Raghav Sundar
Honoraria - Bristol-Myers Squibb; Lilly; MSD
Consulting or Advisory Role - Bristol-Myers Squibb; Eisai
Travel, Accommodations, Expenses - AstraZeneca; Roche; Taiho Pharmaceutical
 
Gloria HJ Chan
No Relationships to Disclose
 
Kritika Yadav
No Relationships to Disclose
 
Valerie Heong
Consulting or Advisory Role - AstraZeneca; Roche
Patents, Royalties, Other Intellectual Property - Royalties received for drug venetoclax
Travel, Accommodations, Expenses - AstraZeneca
 
David Shao Peng Tan
Honoraria - AstraZeneca; Bayer; Foundation Medicine; Janssen; Merck; Roche; Tessa Therapeutics
Consulting or Advisory Role - AstraZeneca; Bayer; Merck; Roche
Speakers' Bureau - Roche
Research Funding - AstraZeneca; Bayer; Karyopharm Therapeutics (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bayer; Merck; Novartis; Roche
 
Ross A. Soo
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Lilly; Merck Sharp & Dohme; Novartis; Pfizer; Roche/Genentech; Taiho Pharmaceutical; Takeda; Yuhan
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Celgene; Merck Sharp & Dohme; Novartis; Pfizer; Roche/Genentech; Taiho Pharmaceutical; Takeda; Yuhan
Research Funding - AstraZeneca
 
Cheng Ean Chee
Consulting or Advisory Role - Bayer
 
Wei-Peng Yong
Honoraria - ASLAN Pharmaceuticals; Bristol-Myers Squibb; MSD Oncology
Speakers' Bureau - Lilly
Travel, Accommodations, Expenses - Pfizer
 
Boon C. Goh
Consulting or Advisory Role - Bayer; Otsuka
Research Funding - Bayer; Genentech/Roche; Kyowa Hakko Kirin
 
Soo-Chin Lee
No Relationships to Disclose